Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.
Pharma giant to acquire biopharma firm specialising in sickle cell treatment | Key treatment will be distributed to countries most impacted by the disease.
Pharma company to acquire biopharma focused on autoimmune, inflammatory and cancer therapeutics / Deal includes acquisition of Tavneos / Spate of acquisitions follows increased competition.
Trade secret suit allegedly cost the pharma company over $1bn | Chinese researcher who stole approximately 200 GSK documents avoids paying restitution | Economic warfare.
Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.
Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Dispute centres on Xifaxan, used to treat irritable bowel syndrome | ‘Significant hurdle’ cleared in bringing drug to market | Bausch wins partial victory after Alvogen subsidiary failed to show that patent claims were obvious.
Nevro sued over the launch of a 10kHz spinal cord stimulation system | Boston Scientific negotiates a worldwide, non-exclusive, non-transferable licence.
Pharma firm joins with patent pool to expand access to HIV treatment | 90 countries set to benefit from preventative medicine
US senator lays into big pharma over ‘Republican-enabled’ tax schemes | Patents for cancer treatment Keytruda allegedly moved offshore.